Invention Grant
- Patent Title: RORgammaT inhibitors
-
Application No.: US15463371Application Date: 2017-03-20
-
Publication No.: US09884043B2Publication Date: 2018-02-06
- Inventor: Willem Frederik Johan Karstens , Mario Van Der Stelt , Jos Cals , Rita Corte Real Goncalves Azevedo , Kenneth Jay Barr , Hongjun Zhang , Richard Thomas Beresis , Dongshan Zhang , Xiaobang Duan
- Applicant: Merck Sharp & Dohme Corp. , Merck Sharp & Dohme B.V.
- Applicant Address: US NJ Rahway NL Haarlem
- Assignee: Merck Sharp & Dohme Corp.,Merck Sharp & Dohme B.V.
- Current Assignee: Merck Sharp & Dohme Corp.,Merck Sharp & Dohme B.V.
- Current Assignee Address: US NJ Rahway NL Haarlem
- Agency: Goodwin Procter LLP
- Priority: EP11154188 20110211
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D401/10 ; C07D401/14 ; A61K31/416 ; A61K31/422 ; C07D231/56 ; A61K31/4245 ; A61K31/437 ; A61K31/4709 ; A61K31/4439 ; C07D471/04 ; C07D413/14 ; C07D413/12 ; C07D409/14 ; C07D403/10 ; C07D401/12 ; C07D401/06 ; A61K45/06
Abstract:
The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.
Public/Granted literature
- US20170340610A1 RORgammaT INHIBITORS Public/Granted day:2017-11-30
Information query
